Illimis Therapeutics Funding: $63M Raised, Series B (2025)

Illimis Therapeutics funding overview

Illimis Therapeutics is based in Seoul, South Korea. Illimis Therapeutics has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2025. The round record for Illimis Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include /DSC Investment/, Woori Venture Partners, Korea Development Bank, Hana Ventures, Aju IB Investment, IMM Investment and 12 others. 18 distinct backers are named across the disclosed rounds.

Illimis Therapeutics at a glance

Total raised: $63M
Latest round: Series B
Latest round date: July 2025
Headquarters: Seoul, South Korea
Notable investors: /DSC Investment/, Woori Venture Partners, Korea Development Bank, Hana Ventures, Aju IB Investment, IMM Investment, LB Investment, GS Ventures

Frequently asked about Illimis Therapeutics funding

How much has Illimis Therapeutics raised?: Illimis Therapeutics has raised $63M in total disclosed funding across the rounds on record.
Who has invested in Illimis Therapeutics?: /DSC Investment/, Woori Venture Partners, Korea Development Bank, Hana Ventures, Aju IB Investment, IMM Investment are named among the investors backing Illimis Therapeutics.
What was the latest Illimis Therapeutics funding round?: The most recent disclosed round is a Series B, announced in July 2025.
Where is Illimis Therapeutics based?: Illimis Therapeutics is based in Seoul, South Korea.
When did Illimis Therapeutics last raise?: The last disclosed Illimis Therapeutics round closed in July 2025 at Series B.

Round data for Illimis Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seoul and backer lists below.

Illimis Therapeutics Funding: $63M Raised, Series B (2025)

Illimis Therapeutics funding overview

Illimis Therapeutics at a glance

Frequently asked about Illimis Therapeutics funding

Companies related to Illimis Therapeutics (18)

Browse related funding lists (9)